Literature DB >> 24852176

Hypertension in postmenopausal women: how to approach hypertension in menopause.

Maria Grazia Modena1.   

Abstract

During fertile life women are usually normo or hypotensive. Hypertension may appear during pregnancy and this represents a peculiar phenomenon increasing nowadays for delay time of pregnancy. Gestational hypertension appears partially similar to hypertension in the context of metabolic syndrome for a similar condition of increased waste circumference. Parity, for the same pathogenesis, has been reported to be associated to peri and postmenopausal hypertension, not confirmed by our study of parous women with transitional non persistent perimenopausal hypertension. Estrogen's deficiency inducing endothelial dysfunction and increased body mass index are the main cause for hypertension in this phase of life. For these reasons lifestyle modification, diet and endothelial active drugs represent the ideal treatment. Antioxidant agents may have a role in prevention and treatment of hypertension. In conclusion, hypertension in women represents a peculiar constellation of different biological and pathogenic factors, which need a specific gender related approach, independent from the male model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24852176     DOI: 10.1007/s40292-014-0057-0

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  4 in total

Review 1.  Hypertension in postmenopausal women: pathophysiology and treatment.

Authors:  Chiara Leuzzi; Maria Grazia Modena
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-03-01

2.  Double-blind randomized placebo-controlled study of transdermal estrogen replacement therapy on hypertensive postmenopausal women.

Authors:  M G Modena; R Molinari; N Muia; A Castelli; F Pala; R Rossi
Journal:  Am J Hypertens       Date:  1999-10       Impact factor: 2.689

3.  Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive postmenopausal women.

Authors:  Rosario Rossi; Annachiara Nuzzo; Giorgia Origliani; Maria Grazia Modena
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

4.  Parity as predictor of early hypertension during menopausal transition.

Authors:  Elisa Giubertoni; Luca Bertelli; Ylenia Bartolacelli; Giorgia Origliani; Maria G Modena
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

  4 in total
  3 in total

1.  Vascular and cognitive effects of cocoa-rich chocolate in postmenopausal women: a study protocol for a randomised clinical trial.

Authors:  Jose A Maderuelo-Fernandez; Jose I Recio-Rodriguez; Irene A Garcia-Yu; Luis Garcia-Ortiz; Manuel A Gómez-Marcos; Rosario Alonso-Dominguez; Jesus Gonzalez-Sanchez; Sara Mora-Simon; Susana González-Manzano; Emiliano Rodriguez-Sanchez
Journal:  BMJ Open       Date:  2018-12-14       Impact factor: 2.692

2.  Early warning score adjusted for age to predict the composite outcome of mortality, cardiac arrest or unplanned intensive care unit admission using observational vital-sign data: a multicentre development and validation.

Authors:  Farah Shamout; Tingting Zhu; Lei Clifton; Jim Briggs; David Prytherch; Paul Meredith; Lionel Tarassenko; Peter J Watkinson; David A Clifton
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

3.  Cardiometabolic Changes in Different Gonadal Female States Caused by Mild Hyperuricemia and Exposure to a High-Fructose Diet.

Authors:  J Soutelo; Y A Samaniego; M C Fornari; C Reyes Toso; O J Ponzo
Journal:  Int J Endocrinol       Date:  2018-08-28       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.